¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

Á¦30ȸ ´ëÇѱâÃÊÀÇÇÐ Çмú´ëȸ (1ÀÏÂ÷)-¿Â/¿ÀÇÁ º´Çà : 2023-06-29

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 

Á¦30ȸ ´ëÇѱâÃÊÀÇÇÐ Çмú´ëȸ (1ÀÏÂ÷)-¿Â/¿ÀÇÁ º´Çà : 2023-06-29
±³À°ÀÏÀÚ : 2023-06-29
±³À°Àå¼Ò : ¿¬¼¼´ëÇб³ ¹Ì·¡Ä·ÆÛ½º ÄÁ¹öÀü½º Ȧ ¹× Çмú´ëȸ ȨÆäÀÌÁö

±³À°ÁÖÁ¦ : Á¦30ȸ ´ëÇѱâÃÊÀÇÇÐ Çмú´ëȸ (1ÀÏÂ÷)-¿Â/¿ÀÇÁ º´Çà

ÁÖÃÖ±â°ü : ´ëÇѱâÃÊÀÇÇÐÇùÀÇȸ
´ã´çÀÚ : ÇѼö¾Æ
¿¬¶ôó : 053-766-0006  

À̸ÞÀÏ : kbms@gbc.or.kr

±³À°Á¾·ù : ÀÇ»çÇÐ, ¹ýÀÇÇÐ, ¿¹¹æÀÇÇÐ, ÇغÎÇÐ, »ý¸®ÇÐ, »ýÈ­ÇÐ, ºÐÀÚ»ý¹°ÇÐ, ¹Ì»ý¹°ÇÐ, ±â»ýÃæÇÐ, ¾à¸®ÇÐ

Âü¼®¿¹»óÀÎ : 1000¸í
Èñ¸ÁÆòÁ¡ : 5Á¡

Áö¿ª : °­¿øµµ
±³À°½Ã°£ : 23 ½Ã°£ 5ºÐ

¼¼ºÎ¼ö°­·á : 100,000¿ø  

ºñ°í ±³¼ö, ÀÇ»ç, ¼±ÀÓ¿¬±¸¿ø, ¿¬±¸±â°ü °ø¹«¿ø (100,000¿ø) / ´ëÇпø»ý, Àü°øÀÇ, ±ºÀÇ°ü, ¿¬±¸¿ø, °£È£»ç, ±âŸ (50,000¿ø) / Çкλý, ÀÇ°ú´ëÇлý, ±âÃʱ³½Ç¸í¿¹±³¼ö (¹«·á)


±¸ºÐ ¿ùÀÏ °­ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ

±³À°½Ã°£ 06¿ù 29ÀÏ 318È£ 10:00~10:30 ±¹³» ÀÇ·á±â±â »ê¾÷ÀÇ ÇöÀç¿Í ¹Ì·¡ ¾ç¸í¹è(¿øÁÖÀÇ·á±â±âÅ×Å©³ë¹ë¸®)

±³À°½Ã°£ 06¿ù 29ÀÏ 318È£ 10:30~11:00 µðÁöÅÐÇコÄÉ¾î °­¿ø±ÔÁ¦ÀÚÀ¯Æ¯±¸ À±¿ÏÅÂ(°­¿øÅ×Å©³ëÆÄÅ©)

±³À°½Ã°£ 06¿ù 29ÀÏ 318È£ 11:00~11:30 µðÁöÅÐÇコ¿Í µ¥ÀÌÅÍÈ°¿ë Á¤»óÅÂ(À²ÃÌ)

±³À°½Ã°£ 06¿ù 29ÀÏ 318È£ 13:00~13:30 ¶óÀÌÇÁ·Î±× ºòµ¥ÀÌÅÍ Ç÷§Æû Ȳ»ó¿ø(¿¬¼¼´ëÇб³ ¿øÁÖÀÇ°ú´ëÇÐ)

±³À°½Ã°£ 06¿ù 29ÀÏ 318È£ 13:30~14:00 µðÁöÅÐÇコ ½Ã´ë Áø·áÁö¿ø Ç÷§Æû ±èÀÍ¿ë(¿¬¼¼´ëÇб³ ¿øÁÖÀÇ°ú´ëÇÐ)

±³À°½Ã°£ 06¿ù 29ÀÏ 318È£ 14:00~14:30 µðÁöÅÐÇコ¿Í ¸ÞŸ¹ö½º Â÷¿øö(»ï¼º¼­¿ïº´¿ø)

±³À°½Ã°£ 06¿ù 29ÀÏ 318È£ 14:30~15:00 ¸ÞµðÄà ƮÀ©°ú µðÁöÅÐÇコ ÀÌÁ¾±Ù(¹Ì¼ÒÁ¤º¸±â¼ú)

±³À°½Ã°£ 06¿ù 29ÀÏ 318È£ 15:00~15:30 ÀÇ·á 3D ¸ðµ¨¸µ ¹Ú»óÁØ(¸ÞµðÄþÆÀÌÇÇ)

±³À°½Ã°£ 06¿ù 29ÀÏ 318È£ 15:30~16:00 The Microbiome as Pharmabiotics ±ÇÈ£±Ù(¿¬¼¼´ëÇб³ ÀÇ°ú´ëÇÐ)

±³À°½Ã°£ 06¿ù 29ÀÏ 318È£ 16:00~16:30 Systems Genetic Analysis of Atherosclerosis and Gut Microbiota in a Diversity Outbred F1 Mouse Population ±è¸í¼®(KIST°­¸ª õ¿¬¹°¿¬±¸¼Ò)

±³À°½Ã°£ 06¿ù 29ÀÏ 318È£ 16:30~17:00 Diverse Microbiome Approaches to Unravel Different Biological Questions ½ÃÁö¿¬(KIST°­¸ª õ¿¬¹°¿¬±¸¼Ò)

±³À°½Ã°£ 06¿ù 29ÀÏ 318È£ 17:00~17:30 Crosstalk Between Bacterial Lipid Immunogens and Human Immune System ¹è¹®Çü(°¡Ãµ´ëÇб³)

±³À°½Ã°£ 06¿ù 29ÀÏ 209È£ 13:30~14:15 ±âÈĺ¯È­¿Í °Ç°­ ±è¹ÌÁö(°æ»ó±¹¸³´ëÇб³ ÀÇ°ú´ëÇÐ)

±³À°½Ã°£ 06¿ù 29ÀÏ 209È£ 14:15~15:00 ±âÈĺ¯È­¿Í ¿øÃ漺 ±â»ýÃæ°¨¿°º´ ´ëÀÀ: Á¢±Ù ¹× Á¦¾îµµ±¸ ³ëÁÖȯ(Çѱ¹ÆĽºÅ𸣿¬±¸¼Ò)

±³À°½Ã°£ 06¿ù 29ÀÏ 209È£ 15:30~16:15 º´¿ø¼º ¸Å°³¸ð±âÀÇ ±âÈĺ¯È­¿¡ µû¸¥ ºÐÆ÷ ÃÖ±¤½Ä(°æºÏ´ëÇб³ »ý¸í°úÇкÎ)

±³À°½Ã°£ 06¿ù 29ÀÏ 209È£ 16:15~17:00 ±¹³» ÂüÁøµå±â ¹× ÂüÁøµå±â ¸Å°³¼º º´¿øüÀÇ ºÐÆ÷¿Í ±âÈĺ¯È­ ½Å¼º½Ä(Àü³²´ëÇб³ ¼öÀÇ°ú´ëÇÐ)

±³À°½Ã°£ 06¿ù 29ÀÏ 103È£ 14:00~14:25 A Precise Pathological Study Targeting Living Individuals ±è¿ëÁØ(°æÈñÀÇ´ë º´¸®Çб³½Ç)

±³À°½Ã°£ 06¿ù 29ÀÏ 103È£ 14:25~14:50 Thoughts on Roles and Rresponsibilities as Bioinformatician in Pathology ¹ÚÀÎÈ£(¿¬¼¼ÀÇ´ë °­³²¼¼ºê¶õ½ºº´¿ø)

±³À°½Ã°£ 06¿ù 29ÀÏ 103È£ 14:50~15:15 Pathology, Biobank and My Studies ä¼öõ(¿ø±¤ÀÇ´ë º´¸®Çб³½Ç)

±³À°½Ã°£ 06¿ù 29ÀÏ 103È£ 15:15~15:40 RNA Cancer Biology in Molecular Pathology ³²¼®¿ì(°¡Å縯ÀÇ´ë º´¸®Çб³½Ç)

±³À°½Ã°£ 06¿ù 29ÀÏ 103È£ 15:40~16:05 A Retrospective of 10 Years as a Toxicologic Pathologist in the Pathology Department of a Major Hospital ¼Õ¿ìÂù(¿ï»êÀÇ´ë ¼­¿ï¾Æ»êº´¿ø)

±³À°½Ã°£ 06¿ù 29ÀÏ 103È£ 16:15~16:40 Role of Patholgists in Drug Development ÃÖÁØÁ¤(¿¬¼¼´ë ¾àÇаú)

±³À°½Ã°£ 06¿ù 29ÀÏ 103È£ 16:40~17:05 A Journey to a Physician-Informatician and Entrepreneur ¹Ú·¡¿õ(¾ÆÁÖÀÇ´ë ÀÇ·áÁ¤º¸Çб³½Ç)

±³À°½Ã°£ 06¿ù 29ÀÏ 103È£ 17:05~17:30 Hospital Pathologists, Public Service Pathologist, and IT Pathologist ±è´ëö(Infinity)

±³À°½Ã°£ 06¿ù 29ÀÏ 323È£ 14:00~14:30 Identification and characterization of new neutrophil populations ¹è¿Ü½Ä(¼º±Õ°ü´ëÇб³ ÀÚ¿¬°úÇдëÇÐ)

±³À°½Ã°£ 06¿ù 29ÀÏ 323È£ 14:30~15:00 The role of novel SiglecF+ neutrophils in fibrosis ±èÇý¿µ(¼­¿ï´ëÇб³ ÀÇ°ú´ëÇÐ)

±³À°½Ã°£ 06¿ù 29ÀÏ 323È£ 15:00~15:30 Role of innate immune sensors and inflammation in viral infections ÀÌ»óÁØ(UNIST »ý¸í°úÇаú)

±³À°½Ã°£ 06¿ù 29ÀÏ 323È£ 16:00~16:30 Macrophage metabolism and inflammation programmed by MsrB1-regulated GAPDH oxidation ±èÁöÇü(°í·Á´ëÇб³ »ý¸í°úÇаú)

±³À°½Ã°£ 06¿ù 29ÀÏ 323È£ 16:30~17:00 Neutrophils fuel non-alcoholic fatty liver disease through lipid delivery È«Àå¿ø(°æºÏ´ëÇб³ ÀÇ°ú´ëÇÐ)

±³À°½Ã°£ 06¿ù 29ÀÏ 323È£ 17:00~17:30 Role of p38 MAPK in the Development of Neutrophil-driven Nonalcoholic Steatohepatitis Ȳ¼ºÈ¯(ºÎ»ê´ëÇб³ ¾àÇдëÇÐ)

±³À°½Ã°£ 06¿ù 29ÀÏ 102È£ 13:30~13:55 In and out of mitosis by BubR1 acetylation/deacetylation ÀÌÇö¼÷(¼­¿ï´ëÇб³ »ý¸í°úÇкÎ)

±³À°½Ã°£ 06¿ù 29ÀÏ 102È£ 13:55~14:20 Mitosis Selective Anti-Cancer Strategy Through Ubiquitination Control ÀÌâ¿ì(¼º±Õ°ü´ëÇб³ ÀÇ°ú´ëÇÐ)

±³À°½Ã°£ 06¿ù 29ÀÏ 102È£ 14:20~14:45 Identification of a novel HASPIN inhibitor and its synergism with the PLK1 inhibitor Â÷ÇõÁø(¼­¿ï´ëÇб³ ¾àÇдëÇÐ)

±³À°½Ã°£ 06¿ù 29ÀÏ 102È£ 14:45~15:10 DOT1L Methyltransferase as a Cell Cycle Regulator ±èÀÚÀº(°æÈñ´ëÇб³ ÀÇ°ú´ëÇÐ)

±³À°½Ã°£ 06¿ù 29ÀÏ 102È£ 15:30~15:55 Dysregulation of the centriole numbers in selected cancer cells À̰Ǽö(¼­¿ï´ëÇб³ »ý¸í°úÇкÎ)

±³À°½Ã°£ 06¿ù 29ÀÏ 102È£ 15:55~16:20 Centrosome mediates mitotic catastrophe induced by DNA damage response Àå⿵(¼÷¸í¿©ÀÚ´ëÇб³ ¾àÇдëÇÐ)

±³À°½Ã°£ 06¿ù 29ÀÏ 102È£ 16:20~16:45 The role of polo-like kinase 1 in hypomethylating treatment failure ±èÀ¯Áø(°¡Å縯´ëÇб³ ÀÇ°ú´ëÇÐ)

±³À°½Ã°£ 06¿ù 29ÀÏ 104È£ 13:40~13:55 ¸ðµç ÀÇ»çµéÀÌ °®Ãß¾î¾ß ÇÒ ¿¹¹æÀÇÇÐ ±³À°À» À§ÇÏ¿©: ÀÇÇаú±³À° ¹ßÀüÀü·« ¿ÀÁÖȯ(¿¹¹æÀÇÇÐȸ ÀÇÇаú ±³À°À§¿øÀå)

±³À°½Ã°£ 06¿ù 29ÀÏ 104È£ 13:55~14:10 »çȸ¿Í °³ÀÎÀ» Á¾ÇÕÀûÀ¸·Î ÀÌÇØÇÏ´Â ÀÇ»ç ¾ç¼ºÀ» À§ÇØ ÇÊ¿äÇÑ ÀÇÇаú ¿¹¹æÀÇÇÐ ±³À° ÀÌ°ü(µ¿±¹ÀÇ´ë ¿¹¹æÀÇÇб³½Ç)

±³À°½Ã°£ 06¿ù 29ÀÏ 104È£ 14:10~14:25 °³ÀÎÀ¸·Î ȯ¿øµÇÁö ¾Ê´Â °Ç°­ÀÇ °áÁ¤¿äÀÎÀ¸·Î¼­ÀÇ È¯°æ¿äÀÎÀ» È¿°úÀûÀ¸·Î ´Ù·ç´Â ÀÇ»ç ¾ç¼ºÀ» À§ÇÑ ÀÇÇаú ±³À° ÇϹ̳ª(´Ü±¹ÀÇ´ë ¿¹¹æÀÇÇб³½Ç)

±³À°½Ã°£ 06¿ù 29ÀÏ 104È£ 14:25~14:40 Áö¿ª»çȸ°Ç°­Çâ»óÀ» À§ÇÑ °³ÀÎÀû °Ç°­°áÁ¤¿äÀÎ º¯È­¸¦ À̲ø ¼ö ÀÖ´Â ¿ª·®À» °®Ãá ÀÇ»ç ¾ç¼ºÀ» À§ÇÑ ÀÇÇаú ±³À° °­À±½Ä(°æ»óÀÇ´ë ¿¹¹æÀÇÇб³½Ç)

±³À°½Ã°£ 06¿ù 29ÀÏ 104È£ 14:40~14:55 °¡Ä¡¿Í Áö¼Ó°¡´É¼ºÀ» ÁöÇâÇÏ´Â ±¹°¡¿Í Áö¿ª»çȸ ÀÇ·á½Ã½ºÅÛ °ü¸® ¿ª·®À» °®Ãá ÀÇ»ç ¾ç¼ºÀ» À§ÇÑ ÀÇÇаú ±³À° ¹ÚÀçÇö(¼º±Õ°üÀÇ´ë »çȸÀÇÇб³½Ç)

±³À°½Ã°£ 06¿ù 29ÀÏ 104È£ 14:55~15:10 ¸ðµç Àǻ簡 °®Ãâ ¼ö ÀÖ´Â ¿¹¹æÀÇÇÐ Áö½Ä°ú ¼Ò¾ç ±³À°À» À§ÇÑ »õ·Î¿î ¿¹¹æÀÇÇÐ ±³°ú¼­ ÆíÂù ±ÇÈ£Àå(¿¹¹æÀÇÇÐ ±³°ú¼­ ÆíÁýÀ§¿øÀå)

±³À°½Ã°£ 06¿ù 29ÀÏ 104È£ 15:10~15:25 ±³À°ÀÇ º¯È­ °üÁ¡¿¡¼­ º» ÀÇÇаú ±³À°ÀÇ ¹Ì·¡ ¸ð¹üÀ¸·Î¼­ÀÇ ¿¹¹æÀÇÇÐ ±³À°ÀÌ µÇ·Á¸é À̽ÂÈñ(¼­¿ïÀÇ´ë ÀÇÇб³À°Çб³½Ç)

±³À°½Ã°£ 06¿ù 29ÀÏ 104È£ 15:25~15:40 ÀÇÇб³À°ÇÐ‧¿¹¹æÀÇÇÐ µ¿½ÃÀû °í·Á¸¦ ÅëÇØ º» ÀÇÇаú ±³À° °úÁ¤¿¡¼­ ¿¹¹æÀÇÇÐÀÇ ¹ßÀüÀû ¿ªÇÒ Ã¤À¯¹Ì(´Ü±¹ÀÇ´ë ÀÇÇб³À°Çб³½Ç)

Åä·Ð 06¿ù 29ÀÏ 104È£ 15:40~16:00 Á¾ÇÕ Åä·Ð ()

±³À°½Ã°£ 06¿ù 29ÀÏ 105È£ 14:10~14:40 An Integrative Approach to Cancer Precision Medicine Á¶¼º¿±(¼­¿ï´ëÇб³)

±³À°½Ã°£ 06¿ù 29ÀÏ 105È£ 14:40~15:10 AD Drug Candidates Targeting Both Amyloid Abnormalities and Neuroinflammation ¾ç½ÂÈÆ(µ¿±¹´ëÇб³)

±³À°½Ã°£ 06¿ù 29ÀÏ 105È£ 15:10~15:40 TLR5: A Promising Therapeutic Target for the Treatment of Various Diseases Á¶°æ¾Æ(Àü³²´ëÇб³)

±³À°½Ã°£ 06¿ù 29ÀÏ 105È£ 16:00~16:30 Deciphering the Novel Intrinsic System in T cells Ȳ¼ö¼®(¿¬¼¼´ëÇб³)

±³À°½Ã°£ 06¿ù 29ÀÏ 105È£ 16:30~17:00 Trend of Therapeutic Intervention Using Stem Cells in Spinal cord Injury À±Å¿µ(°æÈñ´ëÇб³)

 

ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" Á¦30ȸ ´ëÇѱâÃÊÀÇÇÐ Çмú´ëȸ (1ÀÏÂ÷)-¿Â/¿ÀÇÁ º´Çà : 2023-06-29""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û 2023 Á¦2ȸ ÀÌ°ÇÈñ ¼Ò¾Æ¾Ï¡¤Èñ±ÍÁúȯ ±Øº¹»ç¾÷ ¿¬±¸ÀÚ SKILL-UP Workshop : 2023-06-30
´ÙÀ½±Û ±¤Áø±¸ÀÇ»çȸ °³¿øÀÇ ¿¬¼ö°­ÁÂ(ÈäÅë, È£Èí±âÁúȯ) : 2023-06-27
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20694 ´ëÀü Á¦8ȸ ³»ºÐºñ ÃÊÀ½ÆÄ ¹× ±â´É°Ë»ç ¿¬¼ö°­Á : 2024-06-29 0 63 2024-05-11
20693 ¼­¿ï (¿Â¶óÀÎ) ´ëÇѼ¼Æ÷º´¸®ÇÐȸ Á¦32Â÷ º´¸®Àǻ縦 À§ÇÑ ¼¼Æ÷º´¸®±³À° 4Â÷ : 2024-06-29 0 39 2024-05-11
20692 ¼­¿ï Á¦24ȸ ´ëÇÑÀ¯Àü¼º´ë»çÁúȯÇÐȸ Á¤±âÇмú´ëȸ : 2024-06-28 0 47 2024-05-11
20691 °æ±â Á¤½Å°Ç°­ÀÇÇаú ÀÓ»ó¿¡¼­ À¯¿ëÇÑ Ä¡·á¹ý : 2024-06-26 0 53 2024-05-11
20690 ¼­¿ï (¿Â¶óÀÎ)2024 ÇѾç´ëÇб³º´¿ø È£Èí±â¾Ë·¹¸£±â ¿¬¼ö°­Á : 2024-06-22 0 43 2024-05-11
20689 ºÎ»ê °í½Å´ëÇб³º¹À½º´¿ø Á¦20ȸ °©»ó¼±¿¬¼öȸ : 2024-06-22 0 40 2024-05-11
20688 ¼­¿ï (¿Â¶óÀÎ) ´ëÇѼ¼Æ÷º´¸®ÇÐȸ Á¦32Â÷ º´¸®Àǻ縦 À§ÇÑ ¼¼Æ÷º´¸®±³À° 3Â÷ : 2024-06-22 0 17 2024-05-11
20687 ¼­¿ï ´ëÇѺÎÁ¤¸ÆÇÐȸ KHRS Annual Scientific Session 2024 (2ÀÏÂ÷) : 2024-06-22 0 17 2024-05-11
20686 ¼­¿ï Á¦50Â÷ ´ëÇѾÏÇÐȸ Çмú´ëȸ 2 : 2024-06-21 0 35 2024-05-11
20685 ¼­¿ï ´ëÇѺÎÁ¤¸ÆÇÐȸ KHRS Annual Scientific Session 2024 (1ÀÏÂ÷) : 2024-06-21 0 20 2024-05-11
20684 ¼­¿ï Á¦50Â÷ ´ëÇѾÏÇÐȸ Çмú´ëȸ 1 : 2024-06-20 0 18 2024-05-11
20683 ¼­¿ï ´ëÇѸ¶ÃëÅëÁõÀÇÇÐȸ (¿Â¶óÀÎ) ¼­¿ï°æÀÎÁöȸ 277Â÷ ¿ù·ÊÁý´ãȸ : 2024-06-18 0 42 2024-05-11
20682 ¼­¿ï 2024 °­µ¿±¸ÀÇ»çȸ Á¦3Â÷ ¿¬¼ö±³À°(¿°Áõ¼º ÀåÁúȯ,ºñ¸¸ ¾à¹° Ä¡·á ) : 2024-06-17 0 30 2024-05-11
20681 ¼­¿ï ´ëÇÑ´ç´¢º´ÇÐȸ Á¦29Â÷ ´ç´¢º´ ¿¬¼ö°­Á : 2024-06-16 0 32 2024-05-11
20680 ¼­¿ï (¿Â¶óÀÎ) ´ëÇѼ¼Æ÷º´¸®ÇÐȸ Á¦32Â÷ º´¸®Àǻ縦 À§ÇÑ ¼¼Æ÷º´¸®±³À° 2Â÷ : 2024-06-15 0 25 2024-05-11
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷